Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FASLG elevation
i
Other names:
FASLG, APT1LG1, CD178, FasL, TNFSF6, Fas ligand
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
356
Related biomarkers:
Expression
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FASLG elevation
Head and Neck Cancer
FASLG elevation
Head and Neck Cancer
cetuximab
Resistant: C3 – Early Trials
cetuximab
Resistant
:
C3
cetuximab
Resistant: C3 – Early Trials
cetuximab
Resistant
:
C3
FASLG elevation
Pancreatic Ductal Adenocarcinoma
FASLG elevation
Pancreatic Ductal Adenocarcinoma
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
FASLG elevation
Pancreatic Ductal Adenocarcinoma
FASLG elevation
Pancreatic Ductal Adenocarcinoma
nivolumab + ipilimumab
Sensitive: C3 – Early Trials
nivolumab + ipilimumab
Sensitive
:
C3
nivolumab + ipilimumab
Sensitive: C3 – Early Trials
nivolumab + ipilimumab
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login